The HUman MicroNucleus Project - An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 428, Issue 1-2, 1999, Pages 271-283

  Fenech, Michael ^a   Holland, Nina ^b   Chang, Wushou P ^c   Zeiger, Errol ^d   Bonassi, Stefano ^e  

^a CSIRO   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytochalasin B; Cytokinesis block; Epidemiology; Exfoliated cells; Human biomonitoring; Human lymphocytes; Micronucleus

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CARCINOGEN; ENVIRONMENTAL MUTAGEN; PESTICIDE; TOBACCO SMOKE;

BIOLOGICAL MONITORING; CELL TYPE; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONFERENCE PAPER; CYTOKINESIS; DNA DAMAGE; EPITHELIUM CELL; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

CELL DIVISION; DNA DAMAGE; ENVIRONMENTAL MONITORING; EPITHELIAL CELLS; HUMANS; INTERNATIONAL COOPERATION; LYMPHOCYTES; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 0032785259     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00053-8     Document Type: Conference Paper

References (73)

1. Fenech M., Morley A.A. Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low-dose X-irradiation. Mutat. Res. 161:1986;193-198.
2. W.U. Muller, C. Streffer, Micronucleus Assays, in: G. Obe (Ed.), Advances in Mutagenesis Research 5, Springer Verlag, Berlin, 1994, pp. 1-134.
3. Tucker J.D., Preston R.J. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment. Mutat. Res. 365:1996;147-159.
4. Miller B., Albertini S., Locher F., Thybaud V., Lorge E. Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutat. Res. 392:1997;45-59.
5. Kirsch-Volders M. Towards a validation of the micronucleus test. Mutat. Res. 392:1997;1-4.
6. Evans H.J. Historical perspectives on the development of the in vitro micronucleus test: a personal view. Mutat. Res. 392:1997;5-10.
7. Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat. Res. 392:1997;11-18.
8. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody. Environ. Mol. Mutagen. 13:1989;34-43.
9. Fenech M., Morley A.A. Measurement of micronuclei in human lymphocytes. Mutat. Res. 148:1985;29-36.
10. OECD, Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Methods, Paris: Organization for Economic Co-operation and Development, 1996, 60 pp.
11. NIEHS, Validation and Regulatory Acceptance of Toxicological Test Methods, A Report of the Ad Hoc Interagency Coordinating Committee on the Validation of Alternative Methods, National Institute of Environmental Health Sciences, NIH, DHHS, 1997, 105 pp. [available on the internet at http://ntp-server.niehs.nih.gov/htdocs/ICCVAM/ICCVAM.html].
12. Surrales J., Antoccia A., Creus A., Degrassi F., Peris F., Tanzarella C., Xamena N., Marcos R. The effect of cytochalasin-B concentration on the frequency of micronuclei induced by four standard mutagens. Results from two laboratories. Mutagenesis. 9:1994;347-353.
13. Fenech M. Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes - a biomarker for DNA damage in human populations. Mutat. Res. 404:1998;155-165.
14. Barale R., Marrazzini A., Bacci E., DiSibio A., Tessa A., Cocchi L., Scarcelli V., Lubrano V., Vassalle C., Landi S. Sister-chromatid exchange and micronucleus frequency in human lymphocytes of 1650 subjects in an Italian population: I. Contribution of methodological factors. Environ. Mol. Mutagen. 31:1998;218-227.
15. Fenech M., Neville S., Rinaldi J. Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutat. Res. 313:1993;203-207.
16. Bolognesi C., Abbondandolo A., Barale R., Casalone R., Dalpra L., Deferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Migliore L., Padovani P., Pasquini R., Puntoni R., Sbrana L., Stella M., Bonassi S. Age-related increase of base-line frequencies of sister chromatid exchanges, chromosome aberrations and micronuclei in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 6:1997;249-256.
17. Fenech M., Rinaldi J. The relationship between micronuclei in human lymphocytes and plasma levels of vitamin-C, vitamin-E, vitamin-B12 and folic acid. Carcinogenesis. 15:1994;1405-1411.
18. Fenech M., Rinaldi J. A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians. Carcinogenesis. 16:1995;223-230.
19. Fenech M., Perepetskaya G., Mikhalevich L. A more comprehensive application of the micronucleus technique for biomonitoring of genetic damage rates in human populations - experiences from the Chernobyl catastrophe. Environ. Mol. Mutagen. 30:1997;112-118.
20. Fenech M., Aitken C., Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis. 19:1998;1163-1171.
21. M. Kirsch-Volders (Ed.), The CB in vitro micronucleus assay in human lymphocytes, Mutat. Res. 392 (1997b).
22. Chang W.P., Hwang B.F., Wang D., Wang J.D. Cytogenetic effect of chronic low-dose, low-dose-rate gamma-radiation in residents of irradiated buildings. Lancet. 350:1997;330-333.
23. da Silva Augusto L.G., Lieber S.R., Ruiz M.A., de Souza C.A. Micronucleus monitoring to assess human occupational exposure to organochlorides. Environ. Mol. Mutagen. 29:1997;46-52.
24. Chang W.P., Lee S.R., Tu J., Hseu S.S. Increased micronucleus formation in nurses with occupational nitrous oxide exposure in operating theaters. Environ. Mol. Mutagen. 27:1996;93-97.
25. Anwar W.A., Salama S.I., el Serafy M.M., Hemida S.A., Hafez A.S. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs. Mutagenesis. 9:1994;315-317.
26. Tates A.D., van Dam F.J., de Zwart F.A., Darroudi F., Natarajan A.T., Rossner P., Peterkova K., Peltonen K., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., Sram R.J. Biological effect monitoring in industrial workers from the Czech Republic exposed to low levels of butadiene. Toxicology. 113:1996;91-99.
27. Norppa H., Luomahaara S., Heikanen H., Roth S., Sorsa M., Renzi L., Lindholm C. Micronucleus assay in lymphocytes as a tool to biomonitor human exposure to aneuploidogens and clastogens. Environ. Health Perspect. 101(Suppl 3):1993;139-143.
28. Van Hummelen P., Kirsch-Volders M. Analysis of eight known or suspected aneugens by the in vitro human lymphocyte micronucleus test. Mutagenesis. 7:1992;447-455.
29. Van Hummelen P., Elhajouji A., Kirsch-Volders M. Clastogenic and aneugenic effects of three benzimidazole derivatives in the in vitro micronucleus test using human lymphocytes. Mutagenesis. 10:1995;23-29.
30. Tomanin R., Ballarin C., Nardini B., Mastrangelo G., Sarto F. Influence of smoking habit on the frequency of micronuclei in human lymphocytes by the cytokinesis block method. Mutagenesis. 6:1991;123-126.
31. Severin E. Micronucleus frequency in peripheral blood lymphocytes from patients with systemic lupus erythematosus. Romanian J. Morphol. Embryol. 41:1995;55-58.
32. Surralles J., Falck G., Norppa H. In vivo cytogenetic damage revealed by FISH analysis of micronuclei in uncultured human T lymphocytes. Cytogenet. Cell Genet. 75:1996;151-154.
33. Marshall R.R., Murphy M., Kirkland D.J., Bentley K.S. Fluorescence in situ hybridisation with chromosome-specific centromeric probes: a sensitive method to detect aneuploidy. Mutat. Res. 372:1996;233-245.
34. Zijno A., Leopardi P., Marcon F., Crebelli R. Analysis of chromosome segregation by means of fluorescence in situ hybridization: application to cytokinesis-blocked human lymphocytes. Mutat. Res. 372:1996;211-219.
35. Zijno A., Marcon F., Leopardi P., Crebelli R. Simultaneous detection of X-chromosome loss and non-disjunction in cytokinesis-blocked human lymphocytes by in situ hybridization with a centromeric DNA probe; implications for the human lymphocyte in vitro micronucleus assay using cytochalasin B. Mutagenesis. 9:1994;225-232.
36. Nath J., Tucker J.D., Hando J.C. Y chromosome aneuploidy, micronuclei, kinetochores and aging in men. Chromosoma. 103:1995;725-731.
37. Tucker J.D., Nath J., Hando J.C. Activation status of the X chromosome in human micronucleated lymphocytes. Hum. Genet. 97:1996;471-475.
38. Hando J.C., Nath J., Tucker J.D. Sex chromosomes, micronuclei and aging in women. Chromosoma. 103:1994;186-192.
39. Hando J.C., Tucker J.D., Davenport M., Tepperberg J., Nath J. X chromosome inactivation and micronuclei in normal and Turner individuals. Hum. Genet. 100:1997;624-628.
40. Stich H.F., San R.H.C., Rosin M.P. Adaptation of the DNA-repair and micronucleus tests to human cell suspensions and exfoliated cells. Ann. N.Y. Acad. Sci. 407:1983;93-105.
41. Moore L.E., Titenko-Holland N., Quintana P.J.E., Smith M.T. Novel biomarkers of genetic damage in humans: use of fluorescence in situ hybridization to detect aneuploidy and micronuclei in exfoliated cells. J. Toxicol. Environ. Health. 40:1993;355-363.
42. Titenko-Holland N., Levine A.J., Smith M.T., Quintana P.J.E., Boeniger M., Hayes R., Surada A., Sculte P. Quantification of epithelial cell micronuclei by fluorescence in situ hybridization (FISH) in mortuary science students exposed to formaldehyde. Mutat. Res. 371:1996;237-248.
43. Surrales J., Autio K., Nylund L., Jarventaus H., Norppa H., Veidebaum T., Sorsa M., Peltonen K. Molecular cytogenetic analysis of buccal cells and lymphocytes from benzene-exposed workers. Carcinogenesis. 18:1997;817-823.
44. Beli'n J.A.M., Copper M.P., Braakhuis B.J.M., Snow G.B., Baak J.P.A. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis. 16:1995;2395-2400.
45. Casartelli G., Monteghirfo S., Deferrari M., Bonatti S., Scala M., Toma S., Margarino G., Abbondandolo A. Staining of MN in squamous epithelial cells of human oral mucosa. Anal. Quant. Cytol. Histol. 19:1997;475-481.
46. Sarto F., Finotto S., Giacomelli L., Mazzotti D., Tomanin R., Lewis A.G. The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis. 2:1987;11-17.
47. Tolbert P.E., Shy C.M., Allen J.W. Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat. Res. 271:1992;69-77.
48. Stich H.F., Rosin M.P. Micronuclei in exfoliated cells as a tool for studies in cancer risk and cancer intervention. Cancer Lett. 22:1984;241-253.
49. Sarto F., Tomanin R., Giacomelli L., Canova A., Raimondi F., Ghiotto C., Fiorentino M.V. Evaluation of chromosomal aberrations in lymphocytes, oral mucosa and hair root cells of patients under antiblastic therapy. Mutat. Res. 228:1990;157-169.
50. Titenko-Holland N., Moore L., Smith M.T. Measurement and characterization of micronuclei in exfoliated human cells by fluorescence in situ hybridization (FISH) with a centromeric probe. Mutat. Res. 312:1994;39-50.
51. Reali D., DiMarino F., Bahramandpour S., Carducci A., Barale R., Loprieno N. Micronuclei in exfoliated urothelial cells and urine mutagenicity in smokers. Mutat. Res. 192:1987;145-149.
52. Suruda A., Sculte P., Boeniger M., Hayes R.B., Livingston G.K., Steenland K., Stewart P., Herrick R., Douthit D., Fingerhut M.A. Cytogenetic effects of formaldehyde exposure in students of mortuary science. Cancer Epidemiol. Biomarkers Prev. 2:1993;453-460.
53. Ying C.-J., Yan W.-S., Zhao M.-Y., Ye X.-L., Xie H., Yin S.-Y., Zhu X.-S. Micronuclei in nasal mucosa, oral mucosa and lymphocytes in students exposed to formaldehyde vapor in anatomy class. Biomed. Environ. Sci. 10:1997;451-455.
54. R.H.C San, M.P. Rosin, R.H. See, B.P. Dunn, H.F. Stich, Use of urine for monitoring human exposure to genotoxic agents, in: R.G. Wang, C.A. Franklin, R.C. Honeycutt, J.C. Reinert (Eds.), Biological Monitoring for Pesticide Exposure Management, Estimation, and Risk Reduction, ACS Symposium Series 382, Washington, DC, 1989, pp. 98-116.
55. Machado-Santelli G.M., Cerqueira E.M., Oliveira C.T., Pereira C.A. Biomonitoring of nurses handling antineoplastic drugs. Mutat. Res. 322:1994;203-208.
56. Moore L.E., Warner M.L., Smith A.H., Kalman D., Smith M.T. Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in human epithelial cells. Environ. Mol. Mutagen. 27:1996;176-184.
57. Lehucher-Michel M.P., Di Giorgio C., Amara Y.A., Laget M., Botta A. The micronucleus assay in human exfoliated urothelial cells: effect of smoking. Mutagenesis. 10:1995;329-332.
58. Rosin M.P., Anwar W. Chromosomal damage in urothelial cells from Egyptians with chronic Schistosoma haematobium infections. Int. J. Cancer. 50:1992;539-543.
59. Gonzalez Cid M.G., Loria D., Vilensky M., Miotti J.L., Matos E. Leather tanning workers: chromosomal aberrations in peripheral lymphocytes and micronuclei in exfoliated cells in urine. Mutat. Res. 259:1991;197-201.
60. Schatzkin A., Freedman L.S., Shiffman M.H., Dawsey S.M. Validation of intermediate end points in cancer research. J. Natl. Cancer Inst. 82:1990;1746-1752.
61. J.D. Tucker, D.A. Eastmond, L.G. Littlefield, Cytogenetic end-points as biological dosimeters and predictor of risk in epidemiological studies, in: P. Toniolo, P. Boffetta, D.E.G. Shuker, N. Rothman, B. Hulka, N. Pearce (Eds.), Application of Biomarkers in Cancer Epidemiology, IARC Scientific Publication No. 142, 1997, pp. 185-200.
62. Cheng T.J., Christiani D.C., Xu X., Wain J.C., Wiencke J.K., Kelsey K.T. Increased micronucleus frequency in lymphocytes from smokers with lung cancer. Mutat. Res. 349:1996;43-50.
63. Duffaud F., Orsiere T., Villani P., Pelissier A.L., Volot F., Favre R., Botta A. Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis. 12:1997;227-231.
64. Rudd N.L., Hoar D.I., Greentree C.L., Dimnik L.S., Hennig U.G. Micronucleus assay in human fibroblasts: a measure of spontaneous chromosomal instability and mutagen hypersensitivity. Environ. Mol. Mutagen. 12:1988;3-13.
65. Rosin M.P., German J. Evidence for chromosome instability in vivo in Bloom syndrome: increased numbers of micronuclei in exfoliated cells. Hum. Genet. 71:1985;187-191.
66. Benner S.E., Lippman S.M., Wargovich M.J., Lee J.J., Velasco M., Martin J.W., Toth B.B., Hong W.K. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. Int. J. Cancer. 59:1994;457-459.
67. Desai S.S., Ghaisas S.D., Jakhi S.D., Bhide S.V. Cytogenetic damage in exfoliated oral mucosal cells and circulating lymphocytes of patients suffering from precancerous oral lesions. Cancer Lett. 109:1996;9-14.
68. M. Sorsa, J. Wilbourn, H. Vainio, Human cytogenetic damage as a predictor of cancer risk, in: H. Vainio, P.N. Magee, D.B. McGregor, A.J. McMichael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publications No. 116, 1992, pp. 543-554.
69. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., Ames B. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3290-3295.
70. Fenech M., Dreosti I.E., Rinaldi J.R. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis. 18:1997;1329-1336.
71. Rothman N., Stewart W.F., Schulte P.A. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol. Biomarkers Prev. 4:1995;301-311.
72. Hagmar L., Brogger A., Hansteen I.-L., Heim S., Hogstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I., Reuterwall C., Salomaa S., Skerfving S., Sorsa M. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic Study Group on the health risk of chromosome damage. Cancer Res. 54:1994;2919-2922.
73. Bonassi S., Abbondandolo A., Camurri L., Dal Pra' A., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 79:1995;133-135.